- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04977362
Interdisciplinary Perioperative Care in Minimally-invasive Heart Valve Surgery (INCREASE)
December 8, 2024 updated by: Evaldas Girdauskas, Universitätsklinikum Hamburg-Eppendorf
Interdisciplinary and Cross-sectoral Perioperative Care Model in the Cardiac Surgery: Implementation in the Setting of Minimally-invasive Heart Valve Surgery (INCREASE)
Valvular heart diseases are among the most common cardiac pathologies in adult patients in Germany.
Currently, the process of care before, during and after heart valve surgery does not follow a standardized and interdisciplinary optimal approach.
An approach already established in other surgical disciplines is the Enhanced Recovery After Surgery (ERAS) protocol, which aims at optimizing the recovery process of patients.
Within the INCREASE study, a care process inspired by the ERAS protocol will be established at the University Heart and Vascular Center (UHZ) of the University Medical Center Hamburg-Eppendorf (UKE) and the University Medical Center Augsburg (UKA).
Executing the study at two facilities in different regions in Germany will help to demonstrate transferability of the process of care.
The effectiveness of this process compared to the current treatment approach will be investigated in a randomized controlled trial.
A total of 186 patients will be allocated by chance either to the intervention group (ERAS protocol) or the control group (treatment as usual).
Patients in the intervention group will receive an optimized interdisciplinary care protocol including medical, nursing, physiotherapeutical and psychotherapeutical interventions.
Measurements of effectiveness are the number of hospitalized days (due to cardiac causes) within one year and the physical condition of the patient as measured by the 6-minute walk test (6MWT) on the day of discharge.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
201
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hamburg, Germany, 20246
- Universitätsklinikum Hamburg-Eppendorf
-
-
Bavaria
-
Augsburg, Bavaria, Germany, 86156
- Universitätsklinikum Augsburg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Indication for elective minimally invasive (open) aortic or mitral valve surgery
- Patient's ability to understand the nature and extent of the individual's requirements for participation in the new care setting
- Classification of the patient as "FIT" or "Pre-FRAIL" using the LUCAS functional index (frailty index) (Dapp et al. 2012)
Exclusion Criteria:
- Limited life expectancy less than one year (e.g., advanced tumor disease)
- Urgent or emergency interventions
- Severe chronic obstructive pulmonary disease (GOLD III or IV)
- Dialysis-dependant renal failure
- Advanced liver cirrhosis (Child stages B + C)
- Severe comorbidities or psychosocial reasons that militate against participation or do not allow for written informed consent (e. g., residual neurological impairment after prior stroke, major restrictions of mobility, neuropsychological disorders, depressive disorder, substance-related addictive disorders)
- Lack of a social environment that can provide supportive patient care
- Previous cardiac surgery (i.e., relative contraindication for minimally invasive technique)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ERAS protocol (intervention group)
The innovative care process in the intervention group is characterized by an interdisciplinary approach according to the previously established enhanced recovery after surgery protocol.
This process aims at improving the clinical outcome after cardiac surgery, increasing patient satisfaction and quality of life, enabling early professional reentry and participation, and optimizing the cost-effectiveness of service provision.
In addition, intersectoral barriers are being broken down in order to establish an interdisciplinary and cross-sectoral overall care process for patients with heart valve surgery as a new form of care in the future.
|
Enhanced recovery after surgery is a multimodal, transdisciplinary care approach for patients undergoing surgical procedures.
It is implemented in various surgical specialties, among others in cardiac surgery.
The care approach aims at promotion of recovery of the patients throughout their perioperative process, reduction of complications, and early return to normal activities.
Other Names:
|
|
Active Comparator: Treatment as usual (control group)
The control group undergoes standard heart valve surgery.
In this case, no preoperative interventions take place, the patient is operated on the affected heart valve in a minimally invasive procedure without prehabilitation.
After surgery, the patient is transfered to an intensive care unit (not a specialized postanesthesia care unit) depending on the individual condition and then transfered to the general ward.
Patients receive medical, nursing, and physiotherapeutic care in accordance with current hospital standards.
|
treatment as usual according to standard care in heart valve surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospitalization
Time Frame: twelve months
|
number of hospitalized days due to cardiac reasons
|
twelve months
|
|
Six Minute Walk Test
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
physical capacity expressed with the walking distance in meters
|
day of discharge (approx. 5 - 10 days after operation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Goal Attainment Scale (GAS)
Time Frame: three months
|
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
|
three months
|
|
Goal Attainment Scale (GAS)
Time Frame: twelve months
|
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
|
twelve months
|
|
HeartQoL
Time Frame: three months
|
health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life
|
three months
|
|
HeartQoL
Time Frame: twelve months
|
health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life
|
twelve months
|
|
Costs
Time Frame: up to 10 days
|
direct costs in € associated with the operative procedure and the initial hospitalization using diagnosis related groups as classification system, in which diagnoses and treatments are valued according to their necessary economical expenditure
|
up to 10 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
European Health Literacy Questionnaire (HLS-EU-Q16)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy
|
day of discharge (approx. 5 - 10 days after operation)
|
|
European Health Literacy Questionnaire (HLS-EU-Q16)
Time Frame: twelve months
|
health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy
|
twelve months
|
|
Brief Illnness Perception Questionnaire (BIPQ)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Brief Illnness Perception Questionnaire (BIPQ)
Time Frame: twelve months
|
individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception
|
twelve months
|
|
Treatment Expectation Questionnaire (TEX-Q)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Treatment Expectation Questionnaire (TEX-Q)
Time Frame: three months
|
treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment
|
three months
|
|
Treatment Expectation Questionnaire (TEX-Q)
Time Frame: twelve months
|
treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment
|
twelve months
|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: three months
|
depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms
|
three months
|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: twelve months
|
depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms
|
twelve months
|
|
Generalized Anxiety Disorder-2 (GAD-2)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Generalized Anxiety Disorder-2 (GAD-2)
Time Frame: three months
|
anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms
|
three months
|
|
Generalized Anxiety Disorder-2 (GAD-2)
Time Frame: twelve months
|
anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms
|
twelve months
|
|
Cardiac Anxiety Questionnaire (CAQ)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Cardiac Anxiety Questionnaire (CAQ)
Time Frame: three months
|
cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety
|
three months
|
|
Cardiac Anxiety Questionnaire (CAQ)
Time Frame: twelve months
|
cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety
|
twelve months
|
|
Life Orientation Test - revised (LOT-R)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
optimism; 10 items, min 0, max 24, higher scores indicating higher optimism
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Somatic Symptom Scale-8 (SSS-8)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Somatic Symptom Scale-8 (SSS-8)
Time Frame: three months
|
somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden
|
three months
|
|
Somatic Symptom Scale-8 (SSS-8)
Time Frame: twelve months
|
somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden
|
twelve months
|
|
Somatic Symptom Disorder - B Criteria Scale (SSD-12)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Somatic Symptom Disorder - B Criteria Scale (SSD-12)
Time Frame: three months
|
coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms
|
three months
|
|
Somatic Symptom Disorder - B Criteria Scale (SSD-12)
Time Frame: twelve months
|
coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms
|
twelve months
|
|
International Physical Activity Questionnaire Short Form (IPAQ)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
level of physical activity
|
day of discharge (approx. 5 - 10 days after operation)
|
|
International Physical Activity Questionnaire Short Form (IPAQ)
Time Frame: twelve months
|
level of physical activity
|
twelve months
|
|
Hand Dynamometer
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
hand grip strength
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Hand Dynamometer
Time Frame: twelve months
|
hand grip strength
|
twelve months
|
|
1 Minute Sit to Stand Test (1STS)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
physical capacity expressed with the number of repetitions
|
day of discharge (approx. 5 - 10 days after operation)
|
|
1 Minute Sit to Stand Test (1STS)
Time Frame: twelve months
|
physical capacity expressed with the number of repetitions
|
twelve months
|
|
Timed Up and Go (TUG)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
physical capacity expressed with the duration in seconds
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Timed Up and Go (TUG)
Time Frame: twelve months
|
physical capacity expressed with the duration in seconds
|
twelve months
|
|
Six Minute Walk Test
Time Frame: twelve months
|
physical capacity expressed with the walking distance in meters
|
twelve months
|
|
Goal Attainment Scale (GAS)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
|
day of discharge (approx. 5 - 10 days after operation)
|
|
Readiness for Hospital Discharge Scale (RHDS)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
|
readiness for hospital discharge; 9 items, min 0, max 36, higher scores indicating higher readniss to discharge
|
day of discharge (approx. 5 - 10 days after operation)
|
|
5-level EQ-5D Health-related Quality of Life Questionnaire (EQ-5D-5L)
Time Frame: three months
|
health-related quality of life; 6 items, interpretation following an algorythm between 1 (best possible health condition) and <0 (worst possible health condition)
|
three months
|
|
5-level EQ-5D Health-related Quality of Life Questionnaire (EQ-5D-5L)
Time Frame: twelve months
|
health-related quality of life; 6 items, interpretation following an algorythm between 1 (best possible health condition) and <0 (worst possible health condition)
|
twelve months
|
|
Questionnaire for Health-Related Resource Use in an Elderly Population (FIMA)
Time Frame: twelve months
|
use of health care services; 11 items collecting numbers of health care services and days of usage, min 0, higher scores indicating higher usage of services
|
twelve months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Evaldas Girdauskas, Prof., Universitätsklinikum Hamburg-Eppendorf
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kubitz JC, Schulte-Uentrop L, Zoellner C, Lemke M, Messner-Schmitt A, Kalbacher D, Sill B, Reichenspurner H, Koell B, Girdauskas E. Establishment of an enhanced recovery after surgery protocol in minimally invasive heart valve surgery. PLoS One. 2020 Apr 9;15(4):e0231378. doi: 10.1371/journal.pone.0231378. eCollection 2020.
- Petersen J, Kloth B, Konertz J, Kubitz J, Schulte-Uentrop L, Ketels G, Reichenspurner H, Girdauskas E. Economic impact of enhanced recovery after surgery protocol in minimally invasive cardiac surgery. BMC Health Serv Res. 2021 Mar 20;21(1):254. doi: 10.1186/s12913-021-06218-5.
- Klotz SGR, Ketels G, Behrendt CA, Konig HH, Kohlmann S, Lowe B, Petersen J, Stock S, Vettorazzi E, Zapf A, Zastrow I, Zollner C, Reichenspurner H, Girdauskas E. Interdisciplinary and cross-sectoral perioperative care model in cardiac surgery: implementation in the setting of minimally invasive heart valve surgery (INCREASE)-study protocol for a randomized controlled trial. Trials. 2022 Jun 23;23(1):528. doi: 10.1186/s13063-022-06455-x. Erratum In: Trials. 2022 Oct 5;23(1):853. doi: 10.1186/s13063-022-06813-9.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2021
Primary Completion (Actual)
March 24, 2024
Study Completion (Actual)
June 30, 2024
Study Registration Dates
First Submitted
June 18, 2021
First Submitted That Met QC Criteria
July 21, 2021
First Posted (Actual)
July 26, 2021
Study Record Updates
Last Update Posted (Estimated)
December 12, 2024
Last Update Submitted That Met QC Criteria
December 8, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1564/108
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Valve Diseases
-
National University of Ireland, Galway, IrelandNot yet recruitingSurgical Valve Replacement | AORTIC VALVE DISEASES | Valve Disease, Aortic | Valve-in-valve ProceduresIreland
-
IRCCS Policlinico S. DonatoRecruitingMitral Valve Prolapse | Myxomatous Mitral Valve DegenerationItaly
-
Michael MorontRecruitingValve Disease, Heart | Valve Replacement | Valve Heart Stenosis | Valve Regurgitation, MitralUnited States
-
Centro Cardiologico MonzinoAzienda Ospedaliero-Universitaria di Parma; Policlinico SS Annunziata di ChietiActive, not recruitingMitral Regurgitation | Mitral Valve ProlapseItaly
-
Meril Life Sciences Pvt. Ltd.Not yet recruitingAortic Valve Disease, Mitral Valve Disease, Prosthetic Heart Valve Dysfunction | Valvular Heart Disease Requiring Surgical Aortic or Mitral Valve Replacement
-
TRiCaresRecruitingCardiovascular Diseases | Heart Valve Disease | Tricuspid Valve RegurgitationBelgium, Germany
-
University of SalernoActive, not recruitingMitral Valve Failure | AORTIC VALVE DISEASESItaly
-
National Heart, Lung, and Blood Institute (NHLBI)WithdrawnHeart Failure | Aortic Valve Stenosis | Mitral Valve Regurgitation | Heart Valve Disease | Tricuspid Valve RegurgitationUnited States
-
Boston Children's HospitalRecruitingValve Disease, Heart | Valve Heart Disease | Valve Disease, AorticUnited States
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinCompletedMitral Valve Regurgitation | Tricuspid Valve Regurgitation, Non-rheumaticUnited States
Clinical Trials on Enhanced Recovery After Surgery
-
Instituto Brasileiro de Controle do CancerWithdrawnEnhanced Recovery After Surgery | Gynecologic Surgical ProceduresBrazil
-
National Taiwan University HospitalEnrolling by invitationPediatric | Lung Surgery | Enhanced Recovery After Surgery, ERASTaiwan
-
The Second Hospital of Shandong UniversityRecruitingLung Cancer | Surgery | ERASChina
-
Instituto Brasileiro de Controle do CancerRecruitingGynecologic Cancer | Enhanced Recovery After SurgeryBrazil
-
Sixth Affiliated Hospital of Xinjiang Medical UniversityNot yet recruiting
-
University of ThessalyRecruitingPancreatic Cancer Resectable | Enhanced Recovery After Surgery | PancreatectomyGreece
-
Chonnam National University HospitalCompleted
-
The Second Hospital of Shandong UniversityNot yet recruiting
-
Services Hospital, LahoreCompletedEnhanced Recovery After SurgeryPakistan
-
University of Colorado, DenverRecruitingEnhanced Recovery After Surgery | Gynecologic DiseaseUnited States